2026-03-24
The advent of the CAMP platform means that in the future, we may be able to "retrieve" pre-prepared cell-laden bioinks from cell banks as easily as taking out an ice cube, revive them, and immediately use them for 3D printing to construct tissue engineering scaffolds or even organ chips. This breakthrough technology offers a highly promising "ready-to-use" solution for the urgent repair of large tissue defects and the rapid fabrication of personalized implants in clinical settings, with the potential to completely bridge the critical gap from laboratory to operating room.
2026-03-24
"Reviving" Life on a Computer: The First Complete 4D Full-Cycle Simulation of a Minimal Genome Cell
Nonetheless, this newly opened window not only allows us to understand how the simplest form of life operates but also paves the way for simulating more complex human cells in the future.
2026-03-16
Unlocking the Heart's Code: Scientists Discover the Regenerative Seeds to Rejuvenate the Adult Heart
Professor Wang Wei emphasized that this study clarifies the mechanism of the decline in cardiac regeneration at the cellular subpopulation level, providing a brand-new target for myocardial regenerative therapy after MI. Although clinical application still needs to bridge the gap from basic research to translational medicine, this beam of scientific light has illuminated the path to recovery for tens of millions of MI patients.
2026-03-16
In science fiction, human cryopreservation and resuscitation are often regarded as a "time capsule" to the future. Now, this concept has achieved a milestone breakthrough in the laboratory—scientists have for the first time successfully cryopreserved adult mouse brain slices in liquid nitrogen at -196°C and restored multiple key neural functions, including learning and memory mechanisms, after rewarming. This achievement blazes a brand-new trail for basic neuroscience research and organ preservation technology.
2026-03-04
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
2026-02-25
Recently, Xijing Hospital of the Air Force Medical University announced that a team led by Academician Dou Kefeng, in collaboration with the First Affiliated Hospital of Sun Yat-sen University, Tangdu Hospital of the Air Force Medical University, and Sichuan Zhongke Aoger Biotechnology Co., Ltd., successfully completed the world's first surgery using "gene-edited pig liver extracorporeal perfusion" to treat a patient with liver failure. According to a technological novelty search, this procedure has no precedent internationally, marking another milestone breakthrough in the field of clinical xenotransplantation in China.
2026-01-26
Once considered an irreversible "forbidden zone," the spinal cord is now gradually overcoming this cognitive barrier with the advent of NEAT technology. Harnessing the power of science and technology, more patients who have lost mobility due to neural injuries may one day see the dawn of regaining their ability to stand and live independently.
2026-01-26
This research advances the intersection of bioengineering and neuroscience. The constructed "human cerebral vascular chip" represents the first comprehensive simulation of the human cerebral vascular system from structure to function. It provides an unprecedented in vitro platform for exploring cerebral blood flow regulation, BBB mechanisms, and brain diseases closely related to vasculature, such as neuroinflammation, Alzheimer's disease, and stroke.
2026-01-19
Published in Nature, this research marks a shift in tumor immunotherapy from “target blockade” to “cellular fate reprogramming.” With ongoing optimization and clinical exploration of the iVAC platform, it holds promise as a core tool for the next generation of immunotherapies, offering new hope to millions of cancer patients.
2025-12-19
Scientists Crack the "Xenogeneic Barrier", Offering a New Path for Growing Human Organs in Animals
For a long time, human cells have often been excluded and struggled to survive in animal embryos due to the "xenogeneic barrier." The mainstream strategy in the past involved genetically engineering human cells to enhance their anti-apoptotic capabilities, but this approach carries potential safety risks such as carcinogenesis. How can this barrier be overcome more safely? A collaborative team led by the University of Texas Southwestern Medical Center and BGI Research used mice as a model to tackle this issue and achieved a critical breakthrough.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155507
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
